Caitlin Mulligan

Title(s)Assistant Clinical Professor, Neurosciences
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCLAMovement Disorders Fellowship
    UCLA Neurology Residency
    UC IrvineInternal Medicine Internship
    UC San DiegoMDMedical School

    Collapse Overview 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease. Neurobiol Dis. 2021 10; 158:105478. Torres ERS, Stanojlovic M, Zelikowsky M, Bonsberger J, Hean S, Mulligan C, Baldauf L, Fleming S, Masliah E, Chesselet MF, Fanselow MS, Richter F. PMID: 34390837; PMCID: PMC8447919.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    2. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020 05; 38(2):417-432. Mulligan C, Bronstein JM. PMID: 32279718.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    3. Education Research: Evaluation of curriculum to teach resilience skills to neurology residents. Neurology. 2019 03 12; 92(11):538-541. Bursch B, Mulligan C, Keener AM, Aralis H, Lloyd J, Mogil C, Barrera W, Sinclair M, Lester P. PMID: 30858242; PMCID: PMC6511100.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice. Neurobiol Aging. 2017 03; 51:54-66. Richter F, Gabby L, McDowell KA, Mulligan CK, De La Rosa K, Sioshansi PC, Mortazavi F, Cely I, Ackerson LC, Tsan L, Murphy NP, Maidment NT, Chesselet MF. PMID: 28038352; PMCID: PMC5292275.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    5. A GCase chaperone improves motor function in a mouse model of synucleinopathy. Neurotherapeutics. 2014 Oct; 11(4):840-56. Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R, Flanagan J, Lockhart DJ, Wustman BA, Clark SW, Chesselet MF. PMID: 25037721; PMCID: PMC4391384.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    6. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons. Neurobiol Dis. 2014 Sep; 69:263-75. Richter F, Gao F, Medvedeva V, Lee P, Bove N, Fleming SM, Michaud M, Lemesre V, Patassini S, De La Rosa K, Mulligan CK, Sioshansi PC, Zhu C, Coppola G, Bordet T, Pruss RM, Chesselet MF. PMID: 24844147; PMCID: PMC4135465.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    7. Incidence and behavioral correlates of epileptiform abnormalities in autism spectrum disorders. J Autism Dev Disord. 2014 Feb; 44(2):452-8. Mulligan CK, Trauner DA. PMID: 23872941.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    8. Impaired baroreflex function in mice overexpressing alpha-synuclein. Front Neurol. 2013; 4:103. Fleming SM, Jordan MC, Mulligan CK, Masliah E, Holden JG, Millard RW, Chesselet MF, Roos KP. PMID: 23888153; PMCID: PMC3719027.
      View in: PubMed   Mentions: 14  
    9. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Mol Cell Neurosci. 2011 Mar; 46(3):597-606. Fleming SM, Mulligan CK, Richter F, Mortazavi F, Lemesre V, Frias C, Zhu C, Stewart A, Gozes I, Morimoto B, Chesselet MF. PMID: 21193046; PMCID: PMC3046337.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    10. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci. 2008 Jul; 28(2):247-56. Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF. PMID: 18702696; PMCID: PMC3108548.
      View in: PubMed   Mentions: 97     Fields: